Print

Spear Therapeutics Raise $8.5 Million To Fund Cancer Drug Development  
11/28/2005 4:39:09 PM

Cancer Research Technology (CRT), Bloomsbury Bioseed Fund (BBSF), De Montfort University (DMU) and the Gray Cancer Institute announce today that U.S. venture capital firm Advent International has invested $8.5 million in Spear Therapeutics Ltd.
//-->